Tumor Profiling Market

Tumor Profiling Market Size, Share, Growth Analysis, By Technique(Genomics, Proteomics, Metabolomics, Epigenetics), By Technology(Sequencing Techniques, NGS, Sanger Sequencing, Pyro Sequencing), By Application(Personalized Medicine, Oncological Diagnostics, Research, Cancer Research), By Region(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35J2068 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Tumor Profiling Market Insights

Market Overview:

The market for tumour profiling was valued at USD 10.73 billion in 2017 and is anticipated to grow at a CAGR of 8.8% over the next five years. Cancer tumour profiling (CTP) is a procedure to assess a tumor's metabolism, characteristics, and mutations in an effort to find successful treatments. Gene modifications enable the discovery and development of drugs that target these altered kinases. As kinase targeting therapies are dependent on the genetic make-up of individual tumours, cancer tumour profiling is seen as a necessary to increase the sensitivity of these medications. In order to create tailored anti-cancer medicines, these mutated tumour DNA profiles are used.

Tumor Profiling Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Life Sciences Tools & Services by segment aggregation, the contribution of the Life Sciences Tools & Services in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Tumor Profiling was estimated to be valued at US$ XX Mn in 2021.

The Tumor Profiling Market is estimated to grow at a CAGR of XX% by 2028.

The Tumor Profiling Market is segmented on the basis of Technique, Technology, Application, Region.

Based on region, the Tumor Profiling Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Tumor Profiling Market are Illumina Inc., Qiagen N.V., Genomic Health, Neogenomics Inc., Life Sciences, Oxford Gene Technology, Nanostring Technologies, Ribomed Biotechnologies Inc., GenomeDX, Guardant Health, Foundation Medicine.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Tumor Profiling Market

Report ID: UCMIG35J2068

$5,300
BUY NOW GET FREE SAMPLE